Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Current Issues in Pharmacy and Medical Sciences
Volume 36 (2023): Issue 4 (December 2023)
Open Access
New perspectives on the use of glucagon-like peptide 1 in diseases of the central nervous system
Malgorzata Lupina
Malgorzata Lupina
and
Joanna Listos
Joanna Listos
| Dec 25, 2023
Current Issues in Pharmacy and Medical Sciences
Volume 36 (2023): Issue 4 (December 2023)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 25, 2023
Page range:
232 - 235
Received:
Sep 22, 2023
Accepted:
Oct 16, 2023
DOI:
https://doi.org/10.2478/cipms-2023-0040
Keywords
addiction
,
Parkinson disease
,
Alzheimer disease
,
glucagon-like peptide 1
,
neuroprotective effects
,
anti-inflammatory effects
© 2023 Malgorzata Lupina et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Malgorzata Lupina
Department of Experimental and Clinical Pharmacology, Medical University of Lublin
Poland
Joanna Listos
Department of Pharmacology and Pharmacodynamics, Medical University of Lublin
Poland